Certara/CERT

$18.30

8.41%
-
1D1W1MYTD1YMAX

About Certara

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. The Company builds its biosimulation technology on the first principles of biology, chemistry, and pharmacology with mathematical algorithms that model how medicines and diseases behave in the body. It offers an integrated, end-to-end platform for its clients, including various biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries. It also provides an artificial intelligence-powered platform for organizations to integrate and analyze content across their entire enterprise data landscape. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland and the United Kingdom.

Ticker

CERT

Sector

Technology

Trading on

NASDAQ

Industry

Software & Programming

CEO

William Feehery

Employees

1,338

Headquarters

Princeton, United States

Certara Metrics

BasicAdvanced
$2.7B
Market cap
-
P/E ratio
-$0.21
EPS
-
Beta
-
Dividend rate

What the Analysts think about Certara

Analyst Ratings

Majority rating from 10 analysts.
Hold

Price Targets

Average projection from 8 analysts.
5.52% upside
High $21.00
Low $15.50
$18.30
Current price
$19.31
Average price target

Certara Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-14.09% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$88M
2.92%
Net income
$-12.4M
-74.64%
Profit margin
-14.09%
-75.36%

Certara Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 17.43%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.12
$0.12
$0.11
$0.09
-
Expected
$0.12
$0.13
$0.11
$0.11
$0.11
Surprise
-0.83%
-4.55%
0.92%
-17.43%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Certara stock

Buy or sell Certara stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing